• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Matthew Pickering on Working With Health Plans on Measure Implementation

Video

A measure developer's work isn't done once a quality measure is created-the Pharmacy Quality Alliance (PQA) works with health plans post-implementation on questions regarding measure specifications or measure calculations, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at PQA.

A measure developer's work isn't done once a quality measure is created—the Pharmacy Quality Alliance (PQA) works with health plans post-implementation on questions regarding measure specifications or measure calculations, explained Matthew Pickering, PharmD, RPh, associate director of research and quality strategies at PQA.

Transcript

How does the Pharmacy Quality Alliance work with healht plans on implementation of new quality measures?

PQA engages with health plans post-implementation on its measures by answering any questions they may have about how to accurately calculate the measure. Or if there is measure specification questions about how to identify the most eligible population for the measure, the exclusions, etc. So we try to provide feedback for those questions with those health plans, especially with our member organizations who consist of health plans,

We also engage those health plans who are our members in our measure updates. So when we update our measures, we have representatives from those health plans sit in on those panels that provide feedback from what they've experienced in the field based on those measures. And that feedback is very valuable as we think about new specifications or new medications to consider for the update of that measure to when it's implemented again.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.